Sequencing KRAS-Targeted Therapy in G12C Mutated NSCLC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1:20
Sequencing KRAS-Targeted Therapy in G12C Mutated NSCLC …
Feb 21, 2024
targetedonc.com
Treatment of KRAS G12C Mutant NSCLC
Treatment of KRAS G12C Mutant NSCLC
May 11, 2022
onclive.com
Overview of KRAS G12C Mutations in NSCLC | AJMC
Overview of KRAS G12C Mutations in NSCLC | AJMC
2 weeks ago
ajmc.com
Comprehensive Introduction to KRAS G12C Mutation in NSCLC: Patient Identification, Demographics, and Testing
Comprehensive Introduction to KRAS G12C Mutation in NSCLC: P…
64 views8 months ago
vumedi.com
What's Happening in KRAS G12C NSCLC? | OncLive
What's Happening in KRAS G12C NSCLC? | OncLive
Apr 9, 2021
onclive.com
Non–Small Cell Lung Cancer: Optimizing the Identification of KRAS G12C Mutations | OncLive
Non–Small Cell Lung Cancer: Optimizing the Identification of K…
Dec 9, 2022
onclive.com
KRAS G12C Mutation An Emerging Biomarker for NSCLC
KRAS G12C Mutation An Emerging Biomarker for NSCLC
Jan 4, 2021
questdiagnostics.com
How to Personalize the Treatment in Patients With KRAS G12C, KRAS G12D, and KRAS G12V NSCLC
How to Personalize the Treatment in Patients With KRAS G12C, KRAS …
491 viewsNov 3, 2022
vumedi.com
Therapeutic Options for mCRC with KRAS G12C Mutations | OncLive
Therapeutic Options for mCRC with KRAS G12C Mutations | OncLive
Apr 25, 2024
onclive.com
Dr. Klempner on the Significance of KRYSTAL-1 Data in KRAS G12C–Mutant CRC | OncLive
Dr. Klempner on the Significance of KRYSTAL-1 Data in KRAS G12C–…
Nov 9, 2022
onclive.com
KRAS G12C Inhibition in Non-Small Cell Lung Cancer
KRAS G12C Inhibition in Non-Small Cell Lung Cancer
Dec 19, 2020
findkrasg12c.com
KRAS G12C Positive Biliary Tract Cancer: Navigating Treatment Options | OncLive
1:44
KRAS G12C Positive Biliary Tract Cancer: Navigating Treatment Opt…
Dec 4, 2024
onclive.com
Clinical Perspectives of KRAS G12C Inhibitors in NSCLC Mutations | OncLive
1:27
Clinical Perspectives of KRAS G12C Inhibitors in NSCLC Mutations | O…
Dec 7, 2023
onclive.com
#kras #oncology #cancerresearch #drugdiscovery | Jose Ricardo Soares
#kras #oncology #cancerresearch #drugdiscovery | Jose Ricardo So…
3 months ago
linkedin.com
Dr Eng on the Implications of a Real-World Study in KRAS G12C–Mutated CRC | OncLive
Dr Eng on the Implications of a Real-World Study in KRAS G12C…
6 months ago
onclive.com
Dr Boland on the Emergence of KRAS G12C Inhibitors in mCRC | OncLive
Dr Boland on the Emergence of KRAS G12C Inhibitors in mCRC | …
Nov 22, 2023
onclive.com
Dr Desai on the Efficacy of Divarasib Plus Cetuximab in KRAS G12C–Mutant CRC | OncLive
Dr Desai on the Efficacy of Divarasib Plus Cetuximab in KRA…
Apr 18, 2023
onclive.com
2L KRAS Inhibitors for Patients With KRAS G12C–Mutated NSCLC | OncLive
2L KRAS Inhibitors for Patients With KRAS G12C–Mutated NSCLC | On…
2 weeks ago
onclive.com
I/O Therapy in KRAS-Mutant NSCLC With Concomitant STK11 or KEAP1 Mutations | OncLive
I/O Therapy in KRAS-Mutant NSCLC With Concomitant STK11 or KEAP…
Jun 27, 2022
onclive.com
KRAS, EGFR, and the Future of Lung Cancer Treatment
KRAS, EGFR, and the Future of Lung Cancer Treatment
11 months ago
medscape.com
Innovations within Precision Oncology Evolution of a Biomarker a Case Study of KRAS-G12C
Innovations within Precision Oncology Evolution of a Biomarke…
May 12, 2022
questdiagnostics.com
Treatment Options for KRAS-Mutated NSCLC | AJMC
Treatment Options for KRAS-Mutated NSCLC | AJMC
Jul 11, 2022
ajmc.com
The KRAS Conundrum - Oncogenic and Immunologic Profiles of G12C and G12D Mutations #KRAS #science
6:54
The KRAS Conundrum - Oncogenic and Immunologic Profiles of G12…
10 views1 month ago
YouTubeComputational GenomeBiology
Dr Skoulidis on the Methods of Analyzing KRAS G12C Inhibitor Efficacy in NSCLC | OncLive
Dr Skoulidis on the Methods of Analyzing KRAS G12C Inhibitor Ef…
2 weeks ago
onclive.com
Cancer cell biology: mutated KRAS & reciprocal signalling
2:25
Cancer cell biology: mutated KRAS & reciprocal signalling
32.4K viewsApr 14, 2016
YouTubePhospho Biomedical Animation
Sotorasib is approved in the United States to treat KRAS p.G12C–mutated non–small-cell lung cancer. Its efficacy and safety in KRAS p.G12C–mutated pancreatic cancer have been unknown. New research findings are summarized in a short video. https://nej.md/3GfOXNp | The New England Journal of Medicine
2:11
Sotorasib is approved in the United States to treat KRAS p.G12C–mut…
2.6K viewsJan 4, 2023
FacebookThe New England Journal of Medicine
#oncology #precisionmedicine #kras #biotech #pharma #cancerresearch | APO Research Inc.
#oncology #precisionmedicine #kras #biotech #pharma #cancerr…
2 months ago
linkedin.com
KRAS mutation
13:59
KRAS mutation
55.8K viewsApr 1, 2015
YouTubeShomu's Biology
Unlock KRAS G12C for lung cancer treatment decisions
49:07
Unlock KRAS G12C for lung cancer treatment decisions
3K viewsOct 29, 2021
YouTubeCAP TODAY
ASCO 2021 Lung Recap: CodeBreak 100: Sotorasib in KRAS G12C Mutation
5:26
ASCO 2021 Lung Recap: CodeBreak 100: Sotorasib in KRAS G12C Mut…
1.2K viewsJan 20, 2022
YouTubeGlobal Resource for Advancing Cancer Education
See more